1-2 of 2
Paola Lev, PhD
Close
Save search
Sort by
Journal Articles

BCL6 Transcriptionally Reprograms the DLBCL Genome by Forming Distinct Biochemically Active Complexes on Genes Corresponding to Different Pathways.

Free
Jose M. Polo, MS, Katerina Chatzi, PhD, Tania Dell’Oso, PhD, Paola Lev, PhD, Ari Melnick, PhD
Journal: Blood
Blood (2007) 110 (11): 2646.
https://doi.org/10.1182/blood.V110.11.2646.2646
Published: 2007
Journal Articles

BCL6 Programs Lymphoma Cells for Survival and Differentiation through Distinct Biochemical Mechanisms, Both of Which Can Be Therapeutically Targeted.

Free
Samir Parekh, MD, Jose Polo, MSc, Przemyslaw Juszczynski, MD, PhD, Paola Lev, PhD, Stella Ranuncolo, MD, PhD, Georgio Cattoretti, MD, Rita Shaknovich, MD, Margaret Shipp, MD, Ari Melnick, MD
Journal: Blood
Blood (2006) 108 (11): 225.
https://doi.org/10.1182/blood.V108.11.225.225
Published: 2006